References in periodicals archive ?
12,21) In these studies, PAX8 was noted in 95% to 98% for clear cell RCC, 90% to 100% for papillary RCC, 82% to 88% for chromophobe cell RCC, 44% to 71% for sarcomatoid RCC, and 61% to 95% for oncocytoma.
A rhabdoid component may be observed among renal clear cell carcinomas but also in papillary carcinomas, chromophobe cell carcinomas, or collecting duct carcinomas.